Answers are grounded in this paper and cite their sources.
Background Fanconi anemia (FA) is a genetically heterogeneous disorder that may result from biallelic pathogenic variants (PVs) in more than 23 different genes. While FANCA , FANCC , and FANCG account for most reported patients, in other genes, e.g. XRCC2 / FANCU , very few affected individuals have been described. Methods We analyzed a cluster of FA patients in a village in the Jerusalem area. We performed exome sequencing and targeted variant testing. Clinical data were collected from the medical records. Results The study reports three patients from different families, homozygous for the XRCC2 /FANCU (NM_005431.1): chr7-152345927 G > A: c·643C > T; p.(Arg215Ter) variant. Affected individuals exhibit physical abnormalities including microcephaly, thumb anomalies and short stature as well as gonadal failure. Notably, all lacked bone marrow failure or malignancies commonly seen in classical FA. In addition, ten patients from nine different families were clinically diagnosed in the village, most probably affected with the same syndrome. Conclusion The findings confirm the classification of XRCC2/FANCU -related FA as a distinct subgroup and underscore the rarity of XRCC2 PVs. These insights contribute to the understanding of the phenotypic spectrum of FA and emphasize the genetic and historical contexts influencing disease prevalence.
No takes yet. Share an insight, caveat, or question.
May et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: